Bristol-Myers Squibb to Take Part in Goldman Sachs 36th Annual Global Health Care Conference
Get Alerts BMY Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 4.7%
Revenue Growth %: +1.4%
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will take part in Goldman Sachs 36th Annual Global Health Care Conference on Tuesday, June 9, 2015, in Rancho Palos Verdes, CA. Michael Giordano, senior vice president, Head of Development, Oncology, will answer questions about the company at 11:40 a.m. EDT (8:40 a.m. PDT).
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150602006320/en/
Bristol-Myers Squibb Company
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
Ranya
Dajani, 609-252-5330
[email protected]
or
Bill
Szablewski, 609-252-5894
[email protected]
Source: Bristol-Myers Squibb Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) call put ratio 2 calls to 1 put into quarter results and outlook
- Form 8.5 (EPT/RI) - Accrol Group Holdings Plc
- Sungrow Released Annual Report 2023: Operating Revenue Witnessed A Robust Growth of 79.5%
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Goldman Sachs, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!